Kanada - Fransızca - Health Canada

smithkline beecham pharma division of smithkline beecham inc - trifluopérazine (chlorhydrate de trifluopérazine) - comprimé - 2mg - trifluopérazine (chlorhydrate de trifluopérazine) 2mg - phenothiazines

Kanada - Fransızca - Health Canada

smithkline beecham pharma division of smithkline beecham inc - chlorhydrate d'halofantrine - comprimé - 250mg - chlorhydrate d'halofantrine 250mg - antimalarials

Avrupa Birliği - Fransızca - EMA (European Medicines Agency)

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - l'herpès zoster - vaccins - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. l'utilisation de shingrix doit être en conformité avec les recommandations officielles.

Avrupa Birliği - Fransızca - EMA (European Medicines Agency)

glaxosmithkline trading services limited - le zanamivir - grippe humaine - antiviraux à usage systémique - dectova est indiqué pour le traitement de complexes et potentiellement la vie en danger de la grippe a ou b, le virus de l'infection chez les adultes et les patients pédiatriques (âgés de ≥6 mois) quand:le patient du virus de la grippe est connu ou suspecté de l'être résistante aux anti-grippe médicaments autres que le zanamivir, et/orother anti-virale médicaments pour le traitement de la grippe, y compris le zanamivir inhalé, ne sont pas appropriés pour le patient individuel. dectova doit être utilisé selon les recommandations officielles.

Avrupa Birliği - Fransızca - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - belantamab mafodotin - le myélome multiple - agents antinéoplasiques - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Avrupa Birliği - Fransızca - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Avrupa Birliği - Fransızca - EMA (European Medicines Agency)

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - des sérums et immunoglobulines, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Belçika - Fransızca - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma sa-nv - diéthylammonium de diclofénac 11,6 mg/g - eq. diclofénac sodique 10 mg/g - gel - diclofenac

Belçika - Fransızca - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma sa-nv - diéthylammonium de diclofénac 11,6 mg/g - eq. diclofénac sodique 10 mg/g - gel - diclofenac

Avrupa Birliği - Fransızca - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infections respiratoires du virus syncytial - vaccins - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. l'utilisation de ce vaccin doit être en conformité avec les recommandations officielles.